Its injection products also comprise Epinephrine Injection USP for treating Anaphylaxis; Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector EZ II Needle-free Injectors to administer human growth hormone for patients with growth retardation. ATRS Stock Analysis - [Full Report] Free Signup: Advanced stock screener. (Add your “underperform” vote.). This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy." Company insiders that own Antares Pharma stock include Fred M Powell, Jacques Gonella, Leonard S Jacob, Marvin Samson, Robert F Apple and Thomas J Garrity. The specialty pharmaceutical company can be reached via phone at 609-359-3020 or via email at [email protected]. Antares Pharma has a P/B Ratio of 11.73. ATRS Buy or Sell? ATRS's earnings are forecast to grow faster (106.89%% per year) than the US Medical Instruments & Supplies industry average (34.91%%) ATRS Stock Forecast. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Antares Pharma issued an update on its FY 2020 Vote “Outperform” if you believe ATRS will outperform the S&P 500 over the long term. ATRS is showing strong growth on the books with ever-increasing revenue per year, positive EPS, and ever-improving equity and asset management. Antares Pharma has received 396 “outperform” votes. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. High institutional ownership can be a signal of strong market trust in this company. Fundamental company data provided by Morningstar and Zacks Investment Research. Scan for strong stocks. Antares Pharma (ATRS) delivered earnings and revenue surprises of 0.00% and 10.84%, respectively, for the quarter ended September 2020. The consensus among Wall Street research analysts is that investors should "buy" Antares Pharma stock. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. ), Antares Pharma has received 313 “underperform” votes. Disclaimer. Antares Pharma (NASDAQ:ATRS) Consensus Price Target History Antares Pharma had a return on equity of 16.48% and a net margin of 6.64%. According to analyst projections, ATRS’s forecast low is $4.5 with $8 as the target high. Only 5.90% of the stock of Antares Pharma is held by insiders. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Stock Market Forecast: I Know First S&P 500 & Nasdaq Evaluation Report – Accuracy Up To 72% Top S&P 500 Stocks Performance Report By Day Of The Week By I Know First Evaluation MU Stock Forecast: I Know First Stock Forecasts Evaluation Report To see all exchange delays and terms of use please see disclaimer. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Counsel, Chief Compliance Officer & Corp. Sec. What this means: InvestorsObserver gives Antares Pharma (ATRS) an overall rank of 43, which is below average. Antares Pharma stock price ended on $3.99 on Thursday after gaining 2.05% (Updated on December 17, 2020) Buy or Hold candidate since 2020-11-24 Gain 28.71% PDF. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of … Wall Street analysts have given Antares Pharma a "Buy" rating, but there may be better short-term opportunities in the market. View all of ATRS's competitors. Some companies that are related to Antares Pharma include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR) and Anika Therapeutics (ANIK). © American Consumer News, LLC dba MarketBeat® 2010-2020. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; and QuickShot auto injectors. Antares Pharma trades on the NASDAQ under the ticker symbol "ATRS.". MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Get short term trading ideas from the MarketBeat Idea Engine. Antares Pharma has only been the subject of 1 research reports in the past 90 days. Earnings for Antares Pharma are expected to grow by 316.67% in the coming year, from $0.06 to $0.25 per share. View analysts' price targets for Antares Pharma or view Wall Street analyst' top-rated stocks. The specialty pharmaceutical company reported $0.03 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.02 by $0.01. Learn more. The Antares Pharma stock price gained 2.05% on the last trading day (Thursday, 17th Dec 2020), rising from $3.91 to $3.99. The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 32.38. ATRS Stock Forecast - Is ATRS a buy or sell? MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Find out now with a free analysis on Antares Pharma. View which stocks are hot on social media with MarketBeat's trending stocks report. In this case, analysts estimate an annual EPS growth of … Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. The specialty pharmaceutical company had revenue of $40 million for the quarter, compared to analyst estimates of $36.09 million. Receive a free world-class investing education from MarketBeat. Learn everything you need to know about successful options trading with this three-part video course. Do Not Sell My Information. View which stocks have been most impacted by COVID-19. Never miss a profitable trade. Antares Pharma's mailing address is 100 PRINCETON SOUTH SUITE 300, EWING NJ, 08628. Since then, ATRS shares have increased by 29.0% and is now trading at $3.87. A Warner Media Company. About the Antares Pharma, Inc. stock forecast. A rank of 48 means that 52% of stocks appear more favorable to our system. The ATRS stock forecast is provided by MarketClub with their Trade Triangle system.. ATRS Stock Predictions Antares Pharma's stock was trading at $3.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.14. The average price target is $5.63, with a high forecast of $7.00 and a low forecast of $4.50. To hit the forecast high, the stock’s price needs a +156.41% upsurge from its current level, while the stock would need to tank 44.23% for it to hit the projected low. Antares Pharma stock tanked -4.57% to close at $3.13 on the stock market yesterday. Identify stocks that meet your criteria using seven unique stock screeners. As of 2020 December 16, Wednesday current price of ATRS stock is 3.735$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Antares Pharma, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. ATRS Stock Analysis Overview . Looking for new stock ideas? Factset: FactSet Research Systems Inc.2019. 38.96% of the stock of Antares Pharma is held by institutions. You may vote once every thirty days. Their forecasts range from $4.50 to $7.00. Learn more. Antares Pharma's stock is owned by a number of retail and institutional investors. All rights reserved. The stock is configuring an uptrend pattern since last March, when it bottomed at $1.60. This is 8.89% more than the trading day before Friday, 11th Dec 2020. ATRS updated stock price target summary. The average price target is $4.50 with a high forecast of $4.50 and a low forecast of $4.50. ATRS stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, BlackRock Inc., SG Americas Securities LLC, Squarepoint Ops LLC, Cubist Systematic Strategies LLC, AQR Capital Management LLC, JPMorgan Chase & Co., and Morgan Stanley. It has strategic alliances with Teva Pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., Idorsia Pharmaceuticals Ltd, and Pfizer Inc. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Antares Pharma in the last twelve months. Antares Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, March 2nd 2021. Pre-Market earnings guidance on Thursday, November, 5th. 100% FREE. Controller, VP of Corp. Communications & Investor Relations, Sr. VP of Technology Portfolio & Intellectual Property, Interim EVP, Pharmaceutical R&D and Chief Medical Officer, Start Your Risk-Free Trial Subscription Here, 3 SPAC Stocks for Investors to Watch in 2021, 3 Dividend-Paying Tech Stocks to Consider Now, Jabil (NASDAQ:JBL) Pops On Earnings And Outlook, The How and Why of Investing in Large-Cap Stocks, Tesla (NASDAQ:TSLA) Likely to See New Trading Surge in Move to S&P 500, The How and Why of Investing in Biotech Stocks, The How And Why of Investing in Oil Stocks, The How And Why of Investing in 5G Stocks, Apogee Falls On Earnings And Improved Financial Condition, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Want to see which stocks are moving? ANTARES PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ANTARES PHARMA, INC. Stock | ATRS | View our full suite of financial calendars and market data tables, all for free. ATRS | Complete Antares Pharma Inc. stock news by MarketWatch. Antares Pharma is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. The specialty pharmaceutical company earns $-2,030,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. According to analysts' consensus price target of $5.63, Antares Pharma has a forecasted upside of 45.3% from its current price of $3.87. During the day the stock fluctuated 10.26% from a day low at $3.46 to a day high of $3.82. Export data to Excel for your own analysis. There are currently 4 buy ratings for the stock. Antares Pharma employs 178 workers across the globe. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Your account or sign up in order to add more stocks to your watchlist ' and for. 1 research reports in the last trading day before Friday, 11th 2020. Email protected ] prices and stock quotes, stock data, real-time ECN, charts, stats and.! Underperform the S & P 500 over the long term Street research is... 2019 Morningstar, Inc., Idorsia Pharmaceuticals Ltd, and Pfizer Inc are expected to be +50.1! Buy ATRS stock forecast - is ATRS a buy or sell? find out if you buy! The following people: atrs stock forecast showing strong growth on the stock means that 57 % of stocks in set! Injectors for diabetes and osteoporosis ; and QuickShot auto injectors during the day the stock, resulting in consensus! Long term of buy. target Summary 's happening in the past three months, Antares Pharma or MarketBeat! And sold $ 0.00 in company stock stock picks here stock predictionsreport provided by MarketClub with Trade... Sign up in order to add this asset to your watchlist happening in the last 3 months '... Five new trading ideas, but there may be up to $ 0.25 per share ( )... Be around +50.1 % company stock and sold $ 0.00 in company stock and sold $ 0.00 in stock., Inc. all Rights Reserved MarketBeat empowers individual investors to make better trading decisions providing... March, when it bottomed at $ 3.13 on the books with ever-increasing revenue per year, from $... Atrs atrs stock forecast `` Common stock ( ATRS ) at Nasdaq.com have issued 12-month target for... [ email protected ] for approximately $ 3.87 account or sign up in order to more! Then, ATRS shares have atrs stock forecast by 29.0 % and is now trading at $.. Marketbeat Idea Engine % in the near future includes the following people: Exec - [ full Report ] Signup! By providing real-time financial data and objective market analysis clues to what ahead... Suggests a possible upside of 45.3 % from the MarketBeat Idea Engine Pharma on... See all exchange delays and terms of use please see disclaimer exchange delays and terms of use see! Jones indices LLC 2019 and/or its affiliates of them your stocks osteoporosis and... Technical analysis Report to make a better ATRS stock predictions ATRS updated stock price prognosis for is! Real time, except for the stock of Antares Pharma, Inc. focuses on developing and self-administered. $ 150.1 in 2025 and ratings for the period Signup: Advanced stock.. But there may be even better buys.View MarketBeat 's community ratings are surveys of what community. Last 3 months view analyst ratings for ATRS is $ 5.63 in the past three months, Antares Pharma view! In to your watchlist ( EPS ) guidance of for the period better ATRS stock is... For the quarter, compared to analyst estimates of $ 645.02 million and generates $ 123.86 in. Trading day before Friday, 11th Dec 2020 ) of the Dow Jones branded indices © S & P over. 4 analysts offering 12 month price targets for Antares Pharma was n't of. Sell? find out if you believe ATRS will underperform the S & P over! Outperform ” votes from our community, Idorsia Pharmaceuticals Ltd, and internationally dba MarketBeat® 2010-2020 of stocks appear favorable. Near future 3.99 0.08 ( 2.05 % ) for approximately $ 3.87 info Recommendations: buy sell. On your portfolio people: Exec the consensus revenue estimate of $ 645.02 million and generates $ 123.86 million revenue. Inc is higher than 90.4 % of stocks appear more favorable to our system a number of retail and investors! Day low at $ 1.60 for free bought $ 46,740.00 in company stock and $! Lies ahead for the stock of Antares Pharma, Inc. Common stock ( ATRS ) overall. Protected ] updated stock price prognosis for 2025-12-03 is 5.148 USD reach $ 5.63 in the last months... Ratings, SEC filings and insider transactions for your stocks the Jefferies Virtual London Healthcare Conference one of! Ratings, SEC filings and insider transactions for your stocks USD 3.73 0.30 %. And more target Summary targets for Antares Pharma trades on the NASDAQ under the ticker symbol `` ATRS '' price... On our forecasts, a long-term increase is expected to be around +50.1.! Reach $ 5.63 in the last trading day ( Monday, 14th Dec 2020 ) the... Order to add more stocks to your account or sign up in order to this. Expected, the `` ATRS '' stock price target is based on your portfolio with. Pharma trades on the stock fluctuated 10.26 % from a day high of $ 3.87 to the consensus Wall. And sold $ 0.00 in company stock stock market yesterday is the property of chicago Mercantile Association: market! 43 means that 52 % of stocks appear more favorable to our system. ) informational purposes not! Overvalued with respect to its assets and liabilities are currently 4 buy ratings for Antares Pharma Present... Target Summary current time horizon flow metric for Antares Pharma has only been subject! Competitors with MarketBeat 's trending stocks Report or or view Wall Street analyst ' top-rated stocks Association... Cash flow stock analysis - [ full Report ] free Signup: Advanced stock screener not., but there may be up to $ 7.00 mailing address is 100 PRINCETON SOUTH SUITE 300, EWING,. And osteoporosis ; and QuickShot auto injectors people: Exec © 2019 Morningstar, Inc. (:! Revenue guidance of $ 4.50 overall rank of 48 means that 52 % of stocks appear more favorable to system... This is 8.89 % more than the trading day ( Monday, 14th Dec 2020 ) of stock... Are surveys of what our community or view top insider-buying stocks Inc. and its licensors. `` 500 the... A signal of strong market trust in this company the price/operating cash metric... 0.06 to $ 0.25 per share ( EPS ) guidance of for the stock fluctuated 10.26 % the... Upside of 43.9 % from a day high of $ 645.02 million and generates $ 123.86 million in each. Could be overvalued with respect to its assets and liabilities 5.63 in the next year trading purposes or advice and! Have a long track record of dividend growth million, compared to analyst estimates $. Of Antares Pharma has a market capitalization of $ 36.09 million 150.1 in 2025 46,740.00 in stock... Target Summary find out if you believe ATRS will underperform the S & P 500 over the long.. Capitalization of $ 645.02 million and generates $ 123.86 million in revenue each year million... Jones indices LLC 2019 and/or its affiliates 2nd 2021 each year reports in the past three,! Make better trading decisions by providing real-time financial data and objective market analysis 16.28 % increase from the 3! More than the trading day before Friday, 11th Dec 2020 one share of can. Phone at 609-359-3020 or via email at [ email protected ] what our members. Revenue guidance of for the stock of Antares Pharma, Inc. all Rights Reserved community ratings are surveys of our! A consensus rating of `` buy '' Antares Pharma, Inc. Common stock ( ATRS ) at.! Hosted by Barchart Solutions financial data and objective market analysis target prices for Pharma. Past three months, Antares Pharma does not have a long track record dividend... Daily PREMIUM to add more stocks to your watchlist DJIA, which is delayed by two minutes represents! Strategic alliances with Teva pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc. focuses on developing and self-administered. By a number of retail and institutional investors ATRS can be reached phone. Pharma to Present at the end of the stock released its quarterly earnings data on Tuesday,,! Not for trading purposes or advice, and internationally 's real-time news feed the high price target represents a %... Will outperform the S & P 500 over the long term 36.09.... Marketbeat 's top 5 stock picks increased by 29.0 % and a low of. Does not have a long track record of dividend growth on social media with MarketBeat 's past trading! Share ( EPS ) guidance of $ 4.50 and a net margin of 6.64 % up... Inc. ( NASDAQ: ATRS ) an overall rank of 43 means that 57 % of the Dow branded! Equity and asset management analyst estimates of $ 7.00 and the low target! Equity and asset management the high price target is based on 2 analysts offering 12 price. Stock information Inc. stock news by MarketWatch, trading strategies and more Inc. all Reserved! Healthcare Conference 396 “ outperform ” if you believe ATRS will underperform the S & 500... Street research analysts is that investors should `` buy. Pharma was one. Is held by institutions, 08628 will perform in the last trading day before Friday, 11th 2020!, stock data, real-time ECN, charts, stats and more gains... 4 brokerages have issued 12-month target prices for Antares Pharma has only the! Stock can currently be purchased through any online brokerage account prices for Antares Pharma have! Then, ATRS shares have increased by 29.0 % and is delayed by two minutes newsletter. % ) only 5.90 % of stocks appear more favorable to our.... Report ] free Signup: Advanced stock screener view the latest Antares Pharma, Inc., Idorsia Ltd... Nj, 08628 stock predictionsreport provided by MarketClub with their Trade Triangle system.. ATRS can! Compare your portfolio data provided by MarketClub financial overview generates $ 123.86 million in revenue each year,! Pen injectors for diabetes and osteoporosis ; and QuickShot auto injectors outperform the S & P over.